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Abstract: Purpose: The effects of influenza vaccines are unclear for elderly individuals with
disabilities. We use a population-based cohort study to estimate the effects of influenza vaccines
in elderly individuals with and without disabilities. Methods: Data were taken from the National
Health Insurance Research Database and Disabled Population Profile of Taiwan. A total of 2,741,403
adults aged 65 or older were identified and 394,490 were people with a disability. These two groups
were further divided into those who had or had not received an influenza vaccine. Generalized
estimating equations (GEE) were used to compare the relative risks (RRs) of death and hospitalization
across the four groups. Results: 30.78% elderly individuals without a disability and 34.59% elderly
individuals with a disability had vaccinated for influenza. Compared to the unvaccinated elderly
without a disability, the vaccinated elderly without a disability had significantly lower risks in all-cause
mortality (RR = 0.64) and hospitalization for any of the influenza-related diseases (RR = 0.91). Both
the unvaccinated and vaccinated elderly with a disability had significantly higher risks in all-cause
mortality (RR = 1.81 and 1.18, respectively) and hospitalization for any of the influenza-related
diseases (RR = 1.73 and 1.59, respectively). Conclusions: The elderly with a disability had higher
risks in mortality and hospitalization than those without a disability; however, receiving influenza
vaccinations could still generate more protection to the disabled elderly.
Keywords: Influenza vaccination; elderly; disability; mortality; hospitalization
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1. Introduction
Influenza remains a public health concern in Asia, and particularly in Taiwan [1]. The Taiwan
Centers for Diseases Control (TCDC) and Infectious Disease Control Advisory Committee have multiple
health strategies for seasonal influenza prevention in addition to the national influenza vaccination
campaign for controlling the risk of influenza transmission among vulnerable groups and reducing
influenza-associated mortality and hospitalization [1]. The influenza season in Taiwan usually begins
in December and peaks in January or February of the following year [2]. Annual government-funded
influenza vaccination campaigns aim to reduce the transmission of influenza and the associated
mortality and morbidity [1–3]. Initially, Taiwan government-funded vaccines were only offered to
adults ≥65 years [1–5]. Subsequently, people at high risk of developing serious complications and
key spreaders, approximately 25% of the Taiwanese population, are vaccinated free of charge [1,2,4,5]
However, individuals with a disability are not included in the current priority groups [6].
According to our previous studies using the National Health Insurance Research Database
(NHIRD), influenza vaccines can reduce the risks of dementia, hemorrhage, and ischemic stroke
in individuals with chronic kidney disease or atrial fibrillation [7–9]. However, few studies have
demonstrated the observable benefits of influenza vaccine administration in elderly individuals with
disabilities, especially in Asia. The current evidence is insufficient to establish recommendations for
health policies. The question remains of whether influenza-related medical costs, hospitalizations, and
mortality rates can be reduced in elderly individuals with disability through the administration of
influenza vaccines.
To explore the effects of influenza vaccines in elderly individuals with and without a disability, we
used a retrospective cohort study built from NHIRD. The disability status of this population-based cohort
was obtained through linking to the Disabled Population Profile of Taiwan, so that the effectiveness of
the influenza vaccines can be compared between individuals with and without a disability.
2. Methods
2.1. Data Source
In Taiwan, a universal insurance scheme called the National Health Insurance (NHI) was launched
in 1995. The NHI is a national single-payer mandatory-enrollment health insurance program that covers
more than 99.9% of the residents of Taiwan [8]. Data used in this study were retrieved from the NHIRD,
provided by Taiwan’s National Health Insurance Administration and managed by the Health and
Welfare Data Center, under the Ministry of Health and Welfare. This large computerized database
contains all “insurance-covered” outpatient visits, hospitalizations, prescriptions, examinations,
interventions, and related diagnoses. In this study, we used the NHIRD in combination with
the Disabled Population Profile and the Cause of Death Registry. A detailed introduction to the NHIRD
can be found in the literature [10].
In this population-based retrospective cohort study, data from 2014 on subjects aged 65 years
or older were collected from the NHIRD. Disabilities were identified from the Disabled Population
Profile, which contains data on all residents who claimed disability benefits. Disability certificates
in Taiwan have been issued by accreditation of the national social welfare agency and professional
physicians. Individuals with a disability certificate can enjoy many health value-added services and
the benefits of social welfare units in Taiwan. Therefore, if an individual has a disability certificate,
this is a financial burden of the Taiwan government. Thus, Taiwan government agencies do regular
inspections. If a disability certificate is found to be false; its related social welfare institutions and
the physicians will be guilty of criminal law.
After excluding (1) those people who died before the end of 2014; (2) those people who received an
influenza vaccine outside of the free influenza vaccination period (between 1 October and 31 December
2014); and (3) those who received more than one influenza vaccine during the study and follow-up
period (between 1 January 2014, and 30 September 2015); a total of 394,490 individuals with a disability
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and 2,346,913 individuals without a disability who were aged 65 years or older in 2014, were included
in the analysis. Data related to the identification of individuals were encrypted before being released
to the researchers to protect personal privacy. The study was approved by the Chang Gung Medical
Foundation Institutional Review Board (IRB No. 201900240B0).
2.2. Outcome Measures
Four outcome indicators, namely all-cause mortality, hospitalization, length of stay, and inpatient
expenditure due to influenza-related complications during the influenza season were used to evaluate
the effectiveness of the seasonal influenza vaccination. All-cause mortality was determined from
the Cause of Death Registry. Hospitalizations, length of stay, and inpatient expenditures were
determined from the NHIRD for hospital admissions due to influenza-related complications, including
pneumonia (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM]
codes 480–487), respiratory diseases (ICD-9-CM codes 460–466, 480–487, 490–496, and 500–518),
chronic obstructive pulmonary disease (COPD; ICD9-CM codes 491, 492, and 496), respiratory failure
(ICD-9-CM codes 518.81–518.84 and 799.1), heart diseases (ICD-9-CM codes 410–429), hemorrhagic
stroke (ICD-9-CM 430, 431, and 432), and ischemic stroke (ICD-9-CM 433 and 434) [11,12].
The length of stay was measured as days hospitalized either in acute or chronic facilities. Inpatient
expenditures were defined as the sum of inpatient medical expenses, including fees for physician
and nurse care, surgeries or procedures, medications, exams and tests, and hospital stay as well as
copayments and other miscellaneous fees [12].
The effectiveness of the influenza vaccination was evaluated using the outcome measures collected
during peak influenza-like illness (ILI) activity [12,13], based on influenza-surveillance data from
the TCDC. Compared with the previous five influenza seasons, the season of 2014–2015 was only
moderately severe but lasted the longest. According to the surveillance data, ILI activity began to
increase at the beginning of January 2015 and peaked in June, then plateaued at the end of September
2015 [14]. Therefore, the influenza season in this study was defined as the time period between January
and September 2015.
2.3. Measures of Predictors
The primary independent variable, whether the included individuals received the influenza
vaccination, was determined by examining the NHIRD claims data (confirmed using drug codes)
between 1 October 2014, and 31 December 2014, when the seasonal influenza vaccines were administered
free of charge to adults aged 65 years or older in Taiwan. This variable is dichotomized and coded as 1
(received vaccination) and 0 (did not receive vaccination).
Other baseline covariates were incorporated in this analysis, including sex, age, premium-based
monthly salary, urbanization, Charlson comorbidity index (CCI) score, catastrophic illnesses, status
as a long-term care facility resident, and healthcare utilization. The identified elderly were divided
into four groups based on age: 65–69, 70–74, 75–79, and ≥80 years. Premium-based monthly salaries
were divided into ≤NT$19,273, NT$19,274–NT$22,800; NT$22,801–NT$45,800; and ≥NT$45,801 (NT$
represents New Taiwan dollars). Urbanization of the area of residence was stratified into three levels:
urban, suburban, and rural. The CCI scores were categorized as 0, 1–2, 3–4, and ≥5. Healthcare
utilization included the number of outpatient visits, hospitalizations, and health examination over
the course of 9 months prior to October 2014. The number of outpatient department (OPD) visits during
the preceding 9 months was divided into two groups by the median visits of all elderly individuals
aged 65 years and older in Taiwan (fewer than 18 visits versus more than 18 visits).
2.4. Statistical Analysis
Bivariable comparisons of the covariates and influenza status were performed using chi-square
tests. Four comparison groups were formed by cross-tabulating vaccination/no vaccination and
disability/no disability. The generalized estimating equations (GEEs) method was used to compare
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the health outcomes for the four groups, measured between 1 January and 30 September 2015.
The GEE logit estimated the effect of receiving influenza vaccination on the relative risks of death
and hospitalization. The adjusted odds ratio was used as an estimate of relative risk (RR). Thus,
the reduction in mortality and hospitalization was calculated as (1 − RR) × 100%. GEEs with a Poisson
distribution were used to evaluate the length of stay. In addition, because the health care expenditure
appeared to be right-skewed, the GEE model with a log-link and gamma distribution were incorporated.
All analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, North Carolina, USA).
A two-tailed p-value of 0.05 was considered statistically significant.
2.5. Ethics Approval and Consent
Our protocols were reviewed and approved by the Chang Gung Medical Foundation Institutional
Review Board (IRB No. 201900240B0).
3. Results
The study cohort comprised elderly individuals without disability (n = 2,346,913), 722,317 (30.78%)
of whom had received influenza vaccination and 1,624,596 (69.22%) of whom had not, and elderly
individuals with disability (n = 394,490), 136,448 (34.59%) of whom had received influenza vaccination
and the remaining 258,042 (65.41%) of whom had not (Table 1). Among the elderly individuals
without disability, those who were male, older, having a lower premium salary, living in lower level of
urbanization areas, having preexisting medical comorbidities, having a catastrophic illness, or residing
in a long-term care facility had higher influenza vaccination rates. Additionally, people with higher
outpatients visits, having been hospitalized, or having health examinations during the first 9 months
of 2014 had higher influenza vaccination rates too.
Among the elderly individuals with disability, those who were male, older, having a lower
premium salary, having a catastrophic illness, residing in a long-term care facility, or having higher
healthcare utilization had higher influenza vaccination rates. However, influenza vaccination rates
were lower among those who living in more urbanized areas and having no comorbidities (see Table 1).
In Table 2, when the individuals with disability were further divided into two groups, physical and
mental disability, we found that the association patterns were the same as whole individuals with
a disability presented in Table 1. Based on this, our subsequent analyses focus only on comparisons
between the individuals with and without a disability.
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Without IV With IV
p-Value 1
Without IV With IV p-Value
1% % % %








Female 1,469,819 53.62 69.75 30.25 66.18 33.82
Male 1,271,584 46.38 68.60 31.40 64.64 35.36
Age (year) (mean ± SD) 74.53 ± 7.33 73.51 ± 7.16 75.39 ± 6.95 <0.001 76.76 ± 8.01 77.90 ± 7.56 <0.001
65–69 840,533 30.66 77.77 22.23 72.91 27.09
70–74 683,448 24.93 69.33 30.67 66.99 33.01
75–79 529,462 19.31 62.59 37.41 62.55 37.45
=80 687,960 25.10 62.54 37.46 62.12 37.88
Premium salary (NTD) <0.001 <0.001
19,273 884,340 32.26 71.19 28.81 65.70 34.30
19,274-22,800 1,098,738 40.08 65.17 34.83 63.29 36.71
22,801-45,800 461,607 16.84 73.31 26.69 68.89 31.11
=45,801 296,718 10.82 71.87 28.13 67.76 32.24
Urbanization <0.001 <0.001
Urban 1,453,747 53.03 73.12 26.88 68.46 31.54
Suburban 893,278 32.58 65.94 34.06 63.43 36.57
Rural 394,378 14.39 61.80 38.20 60.75 39.25
CCI score <0.001 <0.001
0 2,170,934 79.19 70.67 29.33 67.43 32.57
1 or 2 368,417 13.44 62.69 37.31 61.86 38.14
3 or 4 147,741 5.39 62.33 37.67 61.41 38.59
=5 54,311 1.98 64.54 35.46 62.64 37.36
Catastrophic illnesses <0.001 <0.001
No 2,480,370 90.48 69.37 30.63 65.70 34.30
Yes 261,033 9.52 67.45 32.55 64.35 35.65
Long-term care facility resident <0.001 <0.001
No 2,713,653 98.99 69.32 30.68 66.73 33.27
Yes 27,750 1.01 43.10 56.90 39.73 60.27












Without IV With IV
p-Value 1
Without IV With IV p-Value
1% % % %
Utilization of outpatient care 2 <0.001 <0.001
<18 1,370,072 49.98 76.41 23.59 75.28 24.72
= 18 1,371,331 50.02 61.39 38.61 59.62 40.38
Hospital admission 2 <0.001 <0.001
No 2,357,683 86.00 69.51 30.49 65.83 34.17
Yes 383,720 14.00 67.12 32.88 64.16 35.84
Utilization of health examination services 2 <0.001 <0.001
No 1,969,323 71.84 73.88 26.12 69.85 30.15
Yes 772,080 28.16 57.85 42.15 50.45 49.55
1 Chi-square test; 2 Utilization status during the preceding 9 months; Abbreviations: IV, influenza vaccine; CCI, Charlson Comorbidity Index; NTD, New Taiwan dollar.












Without IV With IV
p-Value 3
Without IV With IV p-Value
3% % % %








Female 198,020 50.20 66.46 33.54 64.62 35.38
Male 196,470 49.80 64.83 35.17 62.72 37.28
Age (year) (mean ± SD) 77.15 ± 7.88 76.60 ± 7.92 77.73 ± 7.46 <0.001 77.92 ± 8.60 79.00 ± 8.16 <0.001
65–69 80,224 20.34 73.15 26.85 71.17 28.83
70–74 81,779 20.73 67.24 32.76 64.69 35.31
75–79 80,924 20.51 62.61 37.39 61.99 38.01
=80 151,563 38.42 62.27 37.73 61.27 38.73













Without IV With IV
p-Value 3
Without IV With IV p-Value
3% % % %
Premium salary (NTD) <0.001 <0.001
19,273 133,071 33.73 66.12 33.88 63.52 36.48
19,274-22,800 161,451 40.93 63.31 36.69 63.07 36.93
22,801-45,800 61,481 15.58 69.22 30.78 66.21 33.79
=45,801 38,487 9.76 68.12 31.88 65.19 34.81
Urbanization <0.001 <0.001
Urban 191,671 48.59 68.77 31.23 66.49 33.51
Suburban 134,518 34.10 63.69 36.31 61.40 38.60
Rural 68,301 17.31 60.85 39.15 59.86 40.14
CCI score <0.001 <0.001
0 252,010 63.88 67.65 32.35 66.09 33.91
1 or 2 81,150 20.57 62.36 37.64 57.66 42.34
3 or 4 41,112 10.42 61.75 38.25 57.37 42.63
=5 20,218 5.13 62.66 37.34 62.14 37.86
Catastrophic illnesses <0.001 <0.001
No 310,708 78.76 65.85 34.15 64.44 35.56
Yes 83,782 21.24 64.69 35.31 62.88 37.12
Long-term care facility resident <0.001 <0.001
No 375,171 95.10 66.80 33.20 66.25 33.75
Yes 19,319 4.90 40.09 59.91 38.39 61.61
Utilization of outpatient care 4 <0.001 <0.001
<18 145,799 36.96 75.27 24.73 75.34 24.66
=18 248,691 63.04 60.16 39.84 55.30 44.70
Hospital admission 4 <0.001 <0.001
No 295,965 75.02 65.92 34.08 65.17 34.83
Yes 98,525 24.98 64.71 35.29 60.38 39.62
Utilization of health examination services 4 <0.001 <0.001
No 304,258 77.13 69.89 30.11 69.55 30.45
Yes 90,232 22.87 51.38 48.62 43.34 56.66
1 Physical disabilities included visual impairment, hearing impairment, sound and speech impairment, physical disability, multiple disabilities, major organ malfunction, facial injury,
balance impairment, refractory epilepsy, persistent vegetative state, and rare diseases. 2 Mental disabilities included intellectual impairment, dementia, autism, chromosomal abnormalities,
metabolic abnormalities, congenital defects, and psychiatric disorders; 3 Chi-square test; 4 Utilization status during the preceding 9 months; Abbreviations: IV, influenza vaccine; CCI,
Charlson Comorbidity Index; NTD, New Taiwan dollar.
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Table 3 presents the GEE logit analysis results for the effect of receiving influenza vaccination on
the RR of death and hospitalization. After adjustment for age, gender, premium salary, urbanization
level, CCI score, catastrophic illness, status as a long-term care facility resident, and the number of
outpatient visits, hospital admission, and utilization of health examination services, we analyzed
the RR of death and hospitalization. Compared with the unvaccinated elderly without a disability,
the RR of all-cause death was lower in vaccinated elderly individuals without a disability (RR = 0.64;
95% confidence interval (CI) = 0.63–0.66). Both unvaccinated and vaccinated elderly individuals with
disability compared with unvaccinated elderly individuals without disability had significantly higher
all-cause mortality rate (RR = 1.81; 95% CI = 1.78–1.84 and RR = 1.18; 95% CI = 1.16–1.21, respectively).
However, vaccinated elderly individuals with a disability had a lower death risk than unvaccinated
elderly individuals with a disability. The GEE analysis revealed that the RRs of hospitalization for
influenza and pneumonia, respiratory diseases, respiratory failure, heart diseases, hemorrhagic stroke,
and ischemic stroke, were significantly decreased in vaccinated elderly individuals without a disability
when compared with the unvaccinated elderly without a disability. However, the RRs of hospitalization
for influenza-related diseases were significantly higher in vaccinated (RR = 1.29–1.85) and unvaccinated
(RR = 1.46–2.06) elderly individuals with a disability compared with unvaccinated elderly individuals
without a disability. Similarly, vaccinated elderly individuals with a disability had a lower risk of
hospitalization than unvaccinated elderly individuals with a disability (Table 3).
The length of stay and medical expenditure, were compared between individuals with and
without a disability, with and without IV, by using GEE, and the results are provided in Table 4.
Among elderly individuals without a disability, the length of stay and medical expenditure during
hospitalization were significantly lower in vaccinated individuals when compared with unvaccinated
individuals. When compared with the unvaccinated elderly without a disability, the vaccinated and
unvaccinated elderly with a disability were significantly associated with a higher length of stay (Exp
(b) = 1.15 and 1.33, respectively) and medical expenditure (Exp (b) = 1.06 and 1.25, respectively) for
any of the influenza-related disease hospitalizations (Table 4).
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Without Disability/with IV (N
= 722,317)
With Disability/ without IV(N
= 258,042)
With Disability/with IV(N =
136,448)
Incident (%) Incident (%) Incident(%) RR
1 95% CI Incident(%) RR
1 95% CI Incident(%) RR
1 95% CI
All-cause death 34.06 27.10 22.05 0.64*** 0.63 - 0.66 88.96 1.81*** 1.78 - 1.84 76.59 1.18*** 1.16 - 1.21
Hospitalization
Influenza or pneumonia 38.00 26.59 30.45 0.88*** 0.86 - 0.89 91.99 2.01*** 1.97 - 2.04 111.84 1.85*** 1.81 - 1.90
Respiratory diseases 58.06 42.55 48.88 0.89*** 0.87 - 0.90 131.09 1.89*** 1.86 - 1.92 153.19 1.72*** 1.69 - 1.75
COPD 21.35 15.15 21.29 1.02 1.00 - 1.04 41.02 1.46*** 1.42 - 1.49 58.33 1.56*** 1.52 - 1.61
Respiratory failure 15.76 11.04 11.42 0.81*** 0.79 - 0.83 42.51 2.06*** 2.01 - 2.12 44.32 1.63*** 1.58 - 1.69
Heart disease 44.33 35.82 41.79 0.95*** 0.94 - 0.97 81.26 1.47*** 1.45 - 1.50 89.17 1.39*** 1.36 - 1.42
Hemorrhagic stroke 2.23 1.99 1.81 0.82*** 0.77 - 0.87 4.11 1.54*** 1.44 - 1.66 3.65 1.30*** 1.17 - 1.43
Ischemic stroke 9.01 8.01 7.88 0.85*** 0.83 - 0.88 15.61 1.50*** 1.44 - 1.55 14.35 1.29*** 1.23 - 1.36
Any of the above disease 87.16 68.16 77.69 0.91*** 0.90 - 0.92 174.77 1.73*** 1.70 - 1.75 197.81 1.59*** 1.56 - 1.62
1 Abbreviations: ref., reference group; IV, influenza vaccine; RR, relative risk; COPD, Chronic obstructive pulmonary disease; CI, confidence interval; 2 All models were analyzed using
the generalized estimating equation. Extraneous factors adjusted in the model were age, gender, premium salary, urbanization level, CCI score, catastrophic illnesses, status as a long-term
care facility resident, outpatient utilization, hospital admission, and utilization of health examination services. * p < 0.05; ** p < 0.01; *** p < 0.001.
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Table 4. Comparing the length of stay and medical expenditure between elderly individuals according to the presence of a disability and according to whether





Without Disability/with IV With Disability/without IV With Disability/with IV
Mean Mean Exp (b) 95% CI Mean Exp (b) 95% CI Mean Exp (b) 95% CI
Length of stay
Influenza or pneumonia 19.36 19.01 0.95*** 0.95 - 0.96 24.18 1.17*** 1.17 - 1.18 22.61 1.05*** 1.05 - 1.06
Respiratory diseases 20.82 19.71 0.93*** 0.93 - 0.94 27.40 1.23*** 1.23 - 1.24 24.62 1.07*** 1.07 - 1.08
COPD 16.03 15.66 0.95*** 0.95 - 0.96 23.25 1.33*** 1.32 - 1.33 20.85 1.14*** 1.13 - 1.15
Respiratory failure 31.94 30.92 0.98*** 0.97 - 0.98 38.65 1.20*** 1.20 - 1.21 33.04 1.04*** 1.03 - 1.04
Heart disease 13.12 11.95 0.91*** 0.91 - 0.91 17.09 1.22*** 1.21 - 1.22 15.39 1.08*** 1.07 - 1.09
Hemorrhagic stroke 25.32 25.09 0.93*** 0.92 - 0.94 25.65 1.04*** 1.02 - 1.05 21.19 0.89*** 0.87 - 0.91
Ischemic stroke 17.97 16.02 0.91*** 0.90 - 0.92 18.98 1.06*** 1.05 - 1.07 16.55 0.94*** 0.93 - 0.96
Any of the above disease 39.04 37.32 0.92*** 0.92 - 0.92 58.38 1.33*** 1.33 - 1.34 53.93 1.15*** 1.15 - 1.15
Medical expenditure
Influenza or pneumonia 127,283 118,958 0.93*** 0.91 - 0.95 152,579 1.13*** 1.11 - 1.15 133,165 0.98* 0.96 - 1.00
Respiratory diseases 144,588 131,018 0.92*** 0.91 - 0.93 173,649 1.14*** 1.13 - 1.16 148,062 0.98 * 0.96 - 1.00
COPD 90,824 86,951 0.95*** 0.93 - 0.97 119,238 1.21*** 1.18 - 1.24 105,366 1.06 *** 1.03 - 1.09
Respiratory failure 273,615 259,611 0.98 0.95 - 1.01 285,946 1.06*** 1.03 - 1.08 243,127 0.94*** 0.91 - 0.97
Heart disease 116,230 106,596 0.94*** 0.93 - 0.96 131,848 1.10*** 1.08 - 1.12 116,959 1.00 0.98 - 1.03
Hemorrhagic stroke 207,191 208,435 0.93*** 0.92 - 0.94 201,859 0.99 0.92 - 1.07 156,093 0.82*** 0.74 - 0.92
Ischemic stroke 104,378 98,026 0.95** 0.92 - 0.98 115,741 1.09*** 1.05 - 1.13 101,478 0.97 0.92 - 1.02
Any of the above disease 283,865 263,189 0.91*** 0.90 - 0.93 384,479 1.25*** 1.23 - 1.26 338,457 1.06*** 1.04 - 1.08
Abbreviations: ref., reference group; IV, influenza vaccine; COPD, chronic obstructive pulmonary disease; 1 All models were analyzed using the generalized estimating equation.
Extraneous factors adjusted in the model were age, gender, premium salary, urbanization level, CCI score, catastrophic illnesses, status as long-term care facility resident, outpatient
utilization, hospital admission, and utilization of health examination services. * p < 0.05; ** p < 0.01; *** p < 0.001.
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Overall, elderly individuals with a disability had an increased susceptibility to influenza-associated
hospitalizations and death than elderly individuals without a disability, and those who were
unvaccinated have a much greater risk than those who were vaccinated. However, vaccine
administrations considerably reduced the rates of influenza-associated hospitalizations and deaths in
elderly individuals with and without a disability.
4. Discussion
The United States Advisory Committee on Immunization Practices advises that routine annual
influenza vaccination is recommended for all persons aged ≥ 6 months without contraindications [15].
High-risk individuals, such as the elderly aged ≥65 years, patients with chronic diseases, children
aged 6 through 59 months, those with pregnancy, etc.; their close contacts; and health care workers
should remain high-priority populations in vaccination campaigns [15–18]. Prior to this study, little
evidence suggested that influenza vaccines could reduce influenza-associated mortality and morbidity
in elderly individuals with disabilities.
The term “disability” in the Taiwan Disabled Population Profile refers to individuals with other
chronic health conditions that interfere with or limit their physical, cognitive, or functional capacity [6].
It applies to people with neurological and neurodevelopmental conditions, such as disorders of
the brain, spinal cord, peripheral nerves, and muscles; moderate to severe developmental delay;
muscular dystrophy; and spinal cord injury [6]. For elderly individuals with a disability, their condition
may affect their immune system, which in turn affects their capacity to fight off infections such as
chronic and respiratory diseases, and thus puts them at increased risk of severe illness and need
for hospitalization [6,19–21]. Additionally, they are at risk of influenza-associated mortality and
morbidity due to limited mobility, they may have trouble understanding or practicing preventive
measures, they may be unable to communicate symptoms of illness, and they may not be closely
monitored for symptoms of illness [6,20,21]. Influenza vaccine administration is recommended for
people at high risk of influenza-related complications; however, the effects of influenza vaccine
administration in elderly individuals with disabilities have remained unknown. Therefore, in this
study, we estimated and compared the effects of influenza vaccine administration in elderly individuals
with and without disability.
Age [22], gender [22], salary [23], urbanization level [23], CCI score [24] preexisting major illness
status [25], status as a long-term care facility resident [26], number of outpatient visits [26], hospital
admission [27], and the utilization of health examination services [28] were associated with rates
of influenza-related mortality and hospitalization. In this study, the vaccinated elderly individuals
were more likely to be male, older, having a lower premium salary, having higher CCI scores, having
a catastrophic illnesses, residing in a long-term care facility, having more outpatient visits, hospital
admissions, and use of health examination services. Most of the covariates related to mortality and
hospitalization due to influenza infection have been taken into account and the adjusted results are
presented in Tables 3 and 4.
Our results showed that elderly individuals with disabilities have a higher rate of all-cause
mortality, a longer duration of stay in hospitals, and a higher medical expenditure than elderly
individuals without disabilities. Our results also showed that unvaccinated elderly individuals with
a disability have higher rates of mortality and hospitalization than vaccinated elderly individuals with
a disability (Tables 3 and 4). Additionally, we further stratified the disability individuals into two
groups, physical and mental disability, and repeated the analyses. The results (shown in Tables S1 and
S2) indicate that the overall trends in individuals with a physical disability were similar to those with
a mental disability. Thus, receiving influenza vaccines was associated with lower risks in all-cause
mortality and influenza-related hospitalization, compared to those who did not vaccinate, regardless
of their types of disability. It seems that receiving influenza vaccinations did generate more protection
to all elderly individuals with disabilities.
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The strength of our study was in having the largest cohort of elderly individuals with and without
disability. To the best of our knowledge, no large cohort study has clearly demonstrated the effectiveness
of influenza vaccines in elderly individuals with disabilities. This is the first population-based cohort
study to demonstrate the decrease in all-cause mortality, influenza-related morbidity, the length of
hospital stay, and medical expenditure in elderly individuals with disability as a result of influenza
vaccination. This is also the leading study to demonstrate that elderly individuals with a disability were
more susceptible to influenza-associated mortality and morbidity than elderly individuals without
a disability, especially those who are not vaccinated have a much greater risk than those who are
vaccinated. According to the results of our study, the government should closely monitor and encourage
elderly individuals with disabilities to receive influenza vaccines regularly and the implementation
strategies should be listed as national health policies. Furthermore, strengthened public health
surveillance is needed. Special care for elderly individuals with disabilities can reduce health care
costs and even the national financial burden in the future.
This study has some limitations. First, as all individuals were of Asian ethnicity; therefore, our
findings may not be suitable for extrapolation to non-Asian populations. However, influenza infection
in Asians may be clinically similar to the disease in Caucasians [29]; the aim of future research is
to compare the disease in the two populations. Second, the diagnoses of all comorbid conditions
were based on ICD-9-CM codes. However, to verify the accuracy of the diagnoses, the Health and
Welfare Data Center, under the Ministry of Health and Welfare Administration randomly reviews
charts, interviews individuals, and ensures that hospitals with outlier chargers or practices are audited
and subsequently heavily penalized if malpractice or discrepancies are identified.
In addition, the quality and precision of ICD-9-CM codes in Taiwan have been verified and
demonstrated by previous studies [30,31]. Therefore, we believe the conclusions of this study are
reliable. Nevertheless, to obtain accurate information on population specificity and disease occurrence,
a large-scale randomized trial comparing selected elderly individuals with disabilities who have or
have not received an influenza vaccine is required. Finally, although comprehensive, the NHIRD lacks
information, such as that concerning dietary habits or body mass index, which may be risk factors for
influenza-related mortality.
5. Conclusions
Influenza vaccines reduce the rates of all-cause mortality and influenza-related hospitalization
in elderly individuals with and without disabilities. Elderly individuals with a disability are more
susceptible to mortality and hospitalization compared with unvaccinated elderly individuals without
a disability. Health policies should encourage close monitoring of elderly individuals with a disability
and the promotion of regular influenza vaccinations to reduce mortality and medical expenditure.
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